pharmacopsychiatry
130595
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Pharmacopsychiatry
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
About
Editorial Board
German National License
Imprint
X
Authors
Information for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licencing
AGNP
Official Journal of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie
Collections
Pharmacopsychiatry Women
About Women in Medicine
Open Access
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
1979
1978
1977
1976
1975
1974
1973
1972
1971
1970
1969
1968
Issues
Current Issue
Free Sample Issue (01/2024)
Related Journals
Drug Research
Planta Medica
PiD - Psychotherapie im Dialog
Related Books
Psychiatry / Psychotherapy / Psychosomatic Medicine
Psychotropic Drugs: Risks and Risk Management
Abstracts (HTML)
List of Authors
B
C
D
E
F
G
H
J
K
L
M
O
P
R
S
T
U
V
W
Z
Babl, M
Age- and sex-dependency of psychotropic drug induced hyperprolactinemia
Bangratz, S
Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study
Baumann, P
Matched case-control study: therapeutic drug monitoring in pharmacovigilance
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Citation of the AGNP consensus guidelines for therapeutic drug monitoring in psychiatry 2004 in the scientific literature 2004 to 2011
Ben-Omar, N
Age-dependency of the risk for tricyclic antidepressant-associated anticholinergic adverse reactions
Quantification of thirteen psychotherapeutic agents and their metabolites using column switching HPLC/UV
Boland, K
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization
Brandl, R
Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine
Brocard, M
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Brünen, S
Therapeutic drug monitoring of bupropion for depression
Crettol, S
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Deckert, J
Interaction of valproic acid and antidepressant drugs
Dörfelt, A
Beta-blockers in psychiatry: Pharmacokinetic interactions of antipsychotics with CYP2D6- HPLC as a quantitative method for analysis in TDM
Depressive disorders in childhood and adolescence 2010– a KinderAGATE analysis
Dragicevic, A
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization
Eap, CB
Matched case-control study: therapeutic drug monitoring in pharmacovigilance
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt
Egberts, K
Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice
Eusterschulte, B
Therapeutic drug monitoring (TDM) and clinical outcomes in forensic patients under clozapine therapy compared to therapies with other antipsychotic drugs
Fellgiebel, A
Evaluation of a risk-scale for anticholinergic side-effects in elderly psychiatric inpatients
Frergsen, N
Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy
Fric, M
Therapeutic drug monitoring (TDM) of serotonergic antidepressants in anxiety and obsessive-compulsive disorders
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization
Gerlach, M
Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice
Greil, W
Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients
Grohmann, R
Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients
Gründer, G
Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy
Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt
Haen, E
Measurement of the concentrations of active agents in drugs using UHPLC (Ultra High Pressure Liquid Chromatography) – and HPLC and UV-detection
Beta-blockers in psychiatry: Pharmacokinetic interactions of antipsychotics with CYP2D6- HPLC as a quantitative method for analysis in TDM
Age-dependency of the risk for tricyclic antidepressant-associated anticholinergic adverse reactions
Quantification of thirteen psychotherapeutic agents and their metabolites using column switching HPLC/UV
Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine
Age- and sex-dependency of psychotropic drug induced hyperprolactinemia
The frequency and cost comparison of haloperidol prescriptions – haloperidol data analysis from therapeutic drug monitoring 2006–2011
Haen, W
Depressive disorders in childhood and adolescence 2010– a KinderAGATE analysis
Hahn, M
Increasing drug therapy safety in psychiatry: implementing a pharmacist on the ward
Hansen, D
Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Harenberg, S
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Haueis, P
Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients
Hefner, G
Evaluation of a risk-scale for anticholinergic side-effects in elderly psychiatric inpatients
Henkel, K
Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt
Hiemke, C
Evaluation of a risk-scale for anticholinergic side-effects in elderly psychiatric inpatients
Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization
Citation of the AGNP consensus guidelines for therapeutic drug monitoring in psychiatry 2004 in the scientific literature 2004 to 2011
Therapeutic drug monitoring (TDM) and clinical outcomes in forensic patients under clozapine therapy compared to therapies with other antipsychotic drugs
Therapeutic drug monitoring of bupropion for depression
Hilleret, H
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Himmerich, H
Agomelatine in breast milk
Huemer, J
Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study
Jahner, T
Quantification of thirteen psychotherapeutic agents and their metabolites using column switching HPLC/UV
Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine
Jaquenoud Sirot, E
Matched case-control study: therapeutic drug monitoring in pharmacovigilance
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Lack of response or side effects despite therapeutic dosing: drug-drug interactions? An indication for Therapeutic Drug Monitoring (TDM)
An unusual case of abuse of nasal drops
Jonzier-Perey, M
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Karwautz, A
Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study
Kemmerling, K
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Kirchherr, H
Agomelatine in breast milk
Köber, R
Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine
Köpp, A
Beta-blockers in psychiatry: Pharmacokinetic interactions of antipsychotics with CYP2D6- HPLC as a quantitative method for analysis in TDM
Köppl, A
Measurement of the concentrations of active agents in drugs using UHPLC (Ultra High Pressure Liquid Chromatography) – and HPLC and UV-detection
Koubek, D
Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study
Kullak-Ublick, GA
Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients
Kulpok, C
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice
Laczkovics, C
Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study
Laib, K
Therapeutic drug monitoring of bupropion for depression
Laux, G
Therapeutic drug monitoring (TDM) of serotonergic antidepressants in anxiety and obsessive-compulsive disorders
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization
Lay, C
Rabbit syndrome and akathisia in a patient treated with risperidone
Lichtblau, N
Agomelatine in breast milk
Mader, S
Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study
Mann, K
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization
Mehler-Wex, C
Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice
Melchner, D
Measurement of the concentrations of active agents in drugs using UHPLC (Ultra High Pressure Liquid Chromatography) – and HPLC and UV-detection
Quantification of thirteen psychotherapeutic agents and their metabolites using column switching HPLC/UV
Mendonça Lima, CA
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Merl, E
Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study
Moyses, M
Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study
Müller, MJ
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization
Onuoha, MR
The frequency and cost comparison of haloperidol prescriptions – haloperidol data analysis from therapeutic drug monitoring 2006–2011
Ostad Haji, E
Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization
Outlaw, EM
Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine
Paulzen, M
Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy
Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt
Perrenoud, P
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Pfeifer, P
Therapeutic drug monitoring of bupropion for depression
Pfuhlmann, B
Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice
Interaction of valproic acid and antidepressant drugs
Plener, P
Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice
Powell Golay, K
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Rao, ML
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization
Reich, A
Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt
Riederer, P
Interaction of valproic acid and antidepressant drugs
Roll, SC
Increasing drug therapy safety in psychiatry: implementing a pharmacist on the ward
Russmann, S
Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients
Schäfer, A
Citation of the AGNP consensus guidelines for therapeutic drug monitoring in psychiatry 2004 in the scientific literature 2004 to 2011
Schmidt, FM
Agomelatine in breast milk
Schultze, I
Therapeutic drug monitoring (TDM) and clinical outcomes in forensic patients under clozapine therapy compared to therapies with other antipsychotic drugs
Spisla, C
An unusual case of abuse of nasal drops
Rabbit syndrome and akathisia in a patient treated with risperidone
Stegmann, B
Depressive disorders in childhood and adolescence 2010– a KinderAGATE analysis
Stephan, PL
Matched case-control study: therapeutic drug monitoring in pharmacovigilance
Lack of response or side effects despite therapeutic dosing: drug-drug interactions? An indication for Therapeutic Drug Monitoring (TDM)
Suter, K
Lack of response or side effects despite therapeutic dosing: drug-drug interactions? An indication for Therapeutic Drug Monitoring (TDM)
Tauber, S
Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt
Taurines, R
Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice
Unterecker, S
Interaction of valproic acid and antidepressant drugs
Uribe, MM
Agomelatine in breast milk
Vandel, P
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
van der Velden, JW
Matched case-control study: therapeutic drug monitoring in pharmacovigilance
Veselinovic, T
Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy
Vincent, P
Therapeutic drug monitoring of bupropion for depression
Waldner-Knogler, K
Lack of response or side effects despite therapeutic dosing: drug-drug interactions? An indication for Therapeutic Drug Monitoring (TDM)
Wenzel-Seifert, K
Age-dependency of the risk for tricyclic antidepressant-associated anticholinergic adverse reactions
Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine
Depressive disorders in childhood and adolescence 2010– a KinderAGATE analysis
Age- and sex-dependency of psychotropic drug induced hyperprolactinemia
Wewetzer, C
Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice
Wittmann, K
Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine
Wolf, M
Beta-blockers in psychiatry: Pharmacokinetic interactions of antipsychotics with CYP2D6- HPLC as a quantitative method for analysis in TDM
Zorina, OL
Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients
Zullino, DF
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression